This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order (SPE2DB24FC5NJ) worth $5,174.80 for the supply of 200-unit vials of Botox. The contract, which has no set-aside designation, was awarded by the Defense Logistics Agency (DLA), a defense agency, on August 21, 2024, with a completion date of September 12, 2024.
DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide range of medications and medical supplies to support the recurring medical needs of military health facilities and VA medical centers nationwide. This delivery order is part of a larger $499,999,999 indefinite delivery contract (SPE2DB) held by DMS Pharmaceutical Group with the DLA, which allows the agency to issue firm fixed-price orders for a comprehensive array of pharmaceutical products to fulfill the medical requirements of the Department of Defense.
Generated 11/20/24, 9:26 AM